Przejdź do treści
Global sound
Answers from the Lab

Answers from the Lab

How Pharmacogenomics Deliver More Precise Cancer Therapy

· 21 min · Odcinek 385

Notatki do odcinka

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss updates on the Protecting Access to Medicare Act (PAMA) and other policy changes affecting clinical diagnostics. Later, Dr. Pritt welcomes Ann Moyer, M.D., Ph.D., a molecular genetic pathologist at Mayo Clinic and chair of the hereditary genetics practice, to explore how precision therapeutics are improving cancer treatments.

• PAMA update (00:01): Get the latest on PAMA as the first data collection period begins, including ongoing efforts to advance the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act.
• Policy changes influencing diagnostics (04:09): Learn how evolving reimbursement policies for blood-based cancer screening and a proposed CLIA modernization bill may impact the field.
• Pharmacogenomic tests improving cancer care (08:14): Discover how pharmacogenomics are benefiting patients with cancer, the benefits of medication-based testing, and how this field is advancing.

Resources

• CMS: CLFS & PAMA reporting and resources
• Precision Oncology Therapeutics: Personalized cancer treatment
• Answers From the Lab: Genetic Tests Identify Risk of Irinotecan-Induced Toxicity: John Logan Black, M.D.
• Answers From the Lab: Genetic Tests Identify Risk of Fluoropyrimidine-Induced Toxicity: Ann Moyer, M.D., Ph.D.

Strona: share.transistor.fm

Na żywo, ostatnia godzina: 9 114 utworów na 3 488 stacjach w 125 krajach

Odkrywaj świat przez radio

Więcej sposobów na odkrywanie (7)

Usłyszałeś coś fajnego? Zapisz to albo otwórz od razu w Spotify.

★ Artysta tygodnia Najszybciej rosnący w radiu w tym tygodniu
Twój utwór tutaj? Od € 9 tygodniowo →
Emeradio-AKA-EmmradioSłuchaj dalej